Transcriptome profiling for precision cancer medicine using shallow nanopore cDNA sequencing

Transcriptome profiling is a mainstay of translational cancer research and is increasingly finding its way into precision oncology. While bulk RNA sequencing (RNA-seq) is widely available, high investment costs and long data return time are limiting factors for clinical applications. We investigated...

Descripción completa

Detalles Bibliográficos
Autores principales: Mock, Andreas, Braun, Melissa, Scholl, Claudia, Fröhling, Stefan, Erkut, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911782/
https://www.ncbi.nlm.nih.gov/pubmed/36759549
http://dx.doi.org/10.1038/s41598-023-29550-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911782/
https://www.ncbi.nlm.nih.gov/pubmed/36759549
http://dx.doi.org/10.1038/s41598-023-29550-8

Ejemplares similares